Remove Complication Remove Diabetes Remove Individual Remove Manufacturing
article thumbnail

Degree of Weight Loss Affects Tirzepatide-Linked Cardiometabolic Risk Improvement

Physician's Weekly

“Understanding whether there are specific thresholds of weight reduction associated with minimum or maximum cardiometabolic benefits may assist clinicians in tailoring weight reduction goals to individual patients seeking to reduce their cardiometabolic risk,” the authors write. Bruno Linetzky, M.D.,

article thumbnail

Urinary Incontinence Revisited: George Kuchel & Alison Huang

GeriPal

Incontinence and avoiding issues can present in an older individual, in some cases, just like they do a younger person. Biological aging or physiological aging varies from individual to individual. How do you think about this from a clinical perspective when you’re seeing individuals in your office? Everybody ages.

IT 120
article thumbnail

American Diabetes Association, June 20-23

Physician's Weekly

The annual meeting of the American Diabetes Association was held this year from June 20 to 23 in Chicago, drawing more than 15,000 participants, including clinicians, academicians, allied health professionals, and others interested in diabetes. ” The study was funded by MannKind, the manufacturer of Afrezza. .